Skip to the page

Data / Form D filings / Scribe Therapeutics, Inc.

Scribe Therapeutics, Inc.: Form D filing

Scribe Therapeutics, Inc., a technology company in Alameda, CA, filed a Form D with the SEC in 2021. The latest, on April 2, 2021, reports $100 million sold of a $100 million offering to 19 investors.

Find out what Scribe Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1150 MARINA VILLAGE PKWY, Alameda, CA, 94501
Phone
(510) 454-0213
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2017
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1853921

The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Other Technology: 8,166 rows, $161.66, or the new rows each week for $19.25 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 2, 2021New notice$100,000,002$100,000,002$019Mar 17, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Benjamin OakesExecutive Officer, Director
Vijay PandeDirector
Carl GordonDirector
Behzad AghazadehDirector

Other technology companies in California that filed recently

Every Form D from the week of Mar 29, 2021 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Scribe Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.